Perluigi, M. ., Barone, E. ., Di Domenico, F. ., & Butterfield, D. . (2016). Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways. Biochimica Et Biophysica Acta, 1862(10), 1871-82. https://doi.org/10.1016/j.bbadis.2016.07.005

Tramutola, A. ., Di Domenico, F. ., Barone, E. ., Arena, A. ., Giorgi, A. ., di Francesco, L. ., … Perluigi, M. . (2017). Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology. Antioxidants & Redox Signaling, 26(7), 280-298. https://doi.org/10.1089/ars.2016.6686 (Original work published 2017)

Tramutola, A. ., Arena, A. ., Cini, C. ., Butterfield, D. ., & Barone, E. . (2017). Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology. Expert Review of Neurotherapeutics, 17(1), 59-75. https://doi.org/10.1080/14737175.2017.1246183

Di Domenico, F. ., Barone, E. ., Perluigi, M. ., & Butterfield, D. . (2017). The Triangle of Death in Alzheimer’s Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics. Antioxidants & Redox Signaling, 26(8), 364-387. https://doi.org/10.1089/ars.2016.6759 (Original work published 2017)

Barone, E. ., Di Domenico, F. ., Cassano, T. ., Arena, A. ., Tramutola, A. ., Lavecchia, M. ., … Perluigi, M. . (2016). Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm. Free Radical Biology & Medicine, 91, 127-42. https://doi.org/10.1016/j.freeradbiomed.2015.12.012

Tramutola, A. ., Di Domenico, F. ., Barone, E. ., Perluigi, M. ., & Butterfield, D. . It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease. Oxidative Medicine and Cellular Longevity, 2016, 2756068. https://doi.org/10.1155/2016/2756068 (Original work published 2016)

Tramutola, A. ., Pupo, G. ., Di Domenico, F. ., Barone, E. ., Arena, A. ., Lanzillotta, C. ., … Perluigi, M. . Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype. Journal of Alzheimer’s Disease : JAD, 52(1), 359-371. https://doi.org/10.3233/JAD-151105 (Original work published 2016)

Barone, E. ., Mancuso, C. ., Di Domenico, F. ., Sultana, R. ., Murphy, M. ., Head, E. ., & Butterfield, D. . (2012). Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. Journal of Neurochemistry, 120(1), 135-46. https://doi.org/10.1111/j.1471-4159.2011.07538.x

Barone, E. ., Cenini, G. ., Sultana, R. ., Di Domenico, F. ., Fiorini, A. ., Perluigi, M. ., … Butterfield, D. . (2012). Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B. Antioxidants & Redox Signaling, 16(12), 1407-20. https://doi.org/10.1089/ars.2011.4124 (Original work published 2012)

Cenini, G. ., Dowling, A. ., Beckett, T. ., Barone, E. ., Mancuso, C. ., Murphy, M. ., … Head, E. . (2012). Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochimica Et Biophysica Acta, 1822(2), 130-8. https://doi.org/10.1016/j.bbadis.2011.10.001